Dr. Ricardo Castellanos, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3100 Avenue E, Madina Regional Hospital, Hondo, TX 78861 Phone: 830-393-3122 |
News Archive
Researchers from Mount Sinai School of Medicine have identified a six-gene signature that can be used in a test to predict survival in men with aggressive prostate cancer, according to new research published in the October issue of The Lancet Oncology.
In celebration of a seminal discovery in cancer biology, Fox Chase Cancer Center will host the Philadelphia Chromosome Symposium: Past, Present and Future, on September 28, 2010, from 8 a.m. to 7 p.m. at The Chemical Heritage Foundation, 315 Chestnut Street, Philadelphia. The event marks the 50th anniversary of the discovery of the first genetic abnormality associated with cancer, and the first to lead to a targeted therapy for cancer.
The Centers for Disease Control has awarded the Indiana University School of Medicine a $2.6 million initial contract with the possibility of nearly $10 million in funding over 5 years to accelerate the real-time ability of local, state and regional entities to share data and information to enhance rapid response to and management of potentially catastrophic infectious disease outbreaks and other public health emergencies.
Marking another significant milestone for GE Healthcare's information technology business, the Ohio Pharmacy Board has approved the company's advanced ePrescribing solution for use by the state's physicians. Ohio is the only state today requiring two-factor authentication.
Nalco Water, an Ecolab company, has introduced a molecular-based test for Legionella that provides results 14-times faster than current culture testing methods to help building and cooling tower operators manage public health risks from the waterborne pathogen.
› Verified 5 days ago